ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO)

Historical Holders from Q2 2022 to Q3 2025

Symbol
ABEO on Nasdaq
CUSIP
00289Y206
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
51.9M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
34.9M
Holdings value
$198M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
95
Number of buys
72
Number of sells
-29
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 9.99% 0% $27.3M $989K 5.18M +3.75% Nantahala Capital Management, LLC Sep 30, 2025
Adage Capital Management, L.P. 8.78% $19.3M 4.41M Adage Capital Management, L.P. Mar 31, 2025
BlackRock, Inc. 5.8% $19.3M 2.95M BlackRock, Inc. Jun 30, 2025
James Russell Revocable Trust 5.3% $18.8M 2.72M James Russell Revocable Trust Sep 16, 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 5.2% $18.5M 2.68M Suvretta Capital Management, LLC Jun 30, 2025
Nantahala Capital Partners Limited Partnership 5.09% $13.8M 2.62M NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP Sep 29, 2025
INTEGRATED CORE STRATEGIES (US) LLC 1.7% $3.54M 810K Millennium Management LLC Mar 31, 2025

Institutional Holders of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 797 $4.21K -$67.7K $5.27 3
2025 Q2 34.9M $198M +$32M $5.68 95
2025 Q1 29.7M $141M -$4.44M $4.76 70
2024 Q4 30.6M $170M +$10.4M $5.57 61
2024 Q3 28.8M $182M -$8.99M $6.32 54
2024 Q2 30.1M $128M +$64.5M $4.24 48
2024 Q1 14.4M $105M +$6.82M $7.25 55
2023 Q4 39.8K $199K +$199K $5.01 1
2023 Q3 12.5M $52.5M +$13.2M $4.21 38
2023 Q2 9.39M $37.9M +$7.73M $4.03 37
2023 Q1 7.53M $21.2M -$2.45M $2.82 33
2022 Q4 7.9M $24.3M +$21.1M $3.08 37
2022 Q3 1.04M $3.16M +$3.05M $3.04 19
2022 Q2 34.8K $169K +$169K $4.86 1